Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proactive Conbercept After Vitrectomy for PDR
NCT05642793Phase 2Unknown
- Sponsor
- Peking University Third Hospital
- Start
- Apr 2022
- Primary completion
- Sep 2023
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of conbercept in proliferative diabetic retinopathy (PDR), sponsored by Peking University Third Hospital. Status: unknown.
02
Drugs
conbercept
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on NCT05642793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05642793.